The largest database of trusted experimental protocols

Ha ubiquitin wt

Manufactured by Addgene
Sourced in United States

HA-ubiquitin-WT is a protein construct that consists of a Hemagglutinin (HA) tag fused to wild-type ubiquitin. Ubiquitin is a small regulatory protein that can be attached to other proteins, marking them for degradation or altering their function. This construct can be used as a tool in various research applications involving the study of ubiquitination and protein regulation.

Automatically generated - may contain errors

4 protocols using ha ubiquitin wt

1

Cloning of Protein Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCR-amplified human p62 was cloned into pcDNA3.1/hygro(+)-Flag, pcDNA3-HA, or pColdI (His) vector. Human AMPKα1 was cloned into pcDNA3-HA vector. The construction of Flag/V5–rKHK-A or Flag/V5–rKHK-C, GST–KHK-A or GST–KHK-C, Flag-rKHK G257R, His-PRPS1, and KHK short hairpin RNA (shRNA) was described previously (32 (link)). Nrf2 CA (with the deletion of amino acids 1 to 89) was cloned into pcDNA3.1/puro(+)-HA. PINK1 and SQSTM1 shRNA were constructed via ligation of an oligonucleotide targeting human PINK1 (5′-GCTGGAGGAGTATCTGATAGG-3′) and p62 (5′-ACTGGACCCATCTGTCTTCAA-3′) into an Xho I–/Mlu I–digested pGIPZ vector, respectively. Flag-, V5-, or GST-tagged rKHK-A S80A, Flag–rKHK-A S80E, Flag-p62 S28E, Flag-p62 S28A, His–p62 S28A, Flag–p62 K7R, and all the shRNA-resistant p62 constructs containing nonsense mutations of C1017T, T1020C, and G1023A were constructed using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). Vectors expressing GFP-LC3, HA-ubiquitin-WT, HA-ubiquitin-K48, and HA-ubiquitin-K63 were purchased from Addgene.
+ Open protocol
+ Expand
2

Gene Overexpression and Mutation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For gene overexpression, the full‐length coding sequences of human CDK1, METTL3, YTHDF2, ACSL4, and UBR5 were chemically synthesized and inserted into pcDNA 3.1 (RRID:Addgene_20 407), pFlag‐CMV‐5a (RRID:Addgene_105 933), pCMV‐Myc (RRID:Addgene_73 365), or pCMV‐HA (RRID:Addgene_15 739) vectors as appropriate. HA‐ubiquitin‐WT was obtained from Addgene (Watertown, MA, USA). Site mutation was conducted using the Q5 Site‐Directed Mutagenesis Kit (#E0554S, New England Biolabs, MA, UK) based on the manufacturer's protocols. All constructs were confirmed by Sanger sequencing. All siRNAs were chemically synthesized by Sangon Biotech (Shanghai, China) and validated. The siRNA targeting sequences are listed in Table S6 (Supporting Information). Cell transfection was carried out using Lipofectamine 3000 reagent (Invitrogen).
+ Open protocol
+ Expand
3

Investigating p53 and CYLD Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flag-P53 was provided by Dr Zhenkun Lou52 (link); HA-CYLD were provided by Dr. Ana Bigas53 (link); CYLD-WT, CYLDR936X and CYLDH871N mutant were provided by Dr. Gilles Courtois8 (link); HA-Ubiquitin-WT (Addgene plasmid 17608), HA-Ubiquitin-K63-only (Addgene plasmid 17606) and HA-Ubiquitin-K48-only (Addgene plasmid 17605) were provided by Dr. Ted Dawson. GFP-p53 (Addgene plasmid 12091) was provided by Dr. T. Jacks. GST-p53 (Addgene plasmid 39479) was provided by Dr. Ie-Ming Shih. PCS2-Flag and pcDNA3-Ha plasmids were used to equalize amount of transfected DNA between samples.
+ Open protocol
+ Expand
4

Molecular Interactions in Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression vectors for Myc-RIPK1, HA-ubiquitin-WT, HA-ubiquitin-K63, HA-ubiquitin-K48, V5-TRAF2, Flag-TRAF4, Flag-TRAF6 and Flag-BHRF1 were from Addgene (Cambridge, MA, USA). The deletion or mutation constructs of LMP1, RIPK1, and RIPK3 were synthesized by Genechem (Shanghai, China), and all of the plasmids were verified by DNA sequencing. Full-length or truncated cDNAs of LMP1 were cloned into BamHI and EcoRI sites of the GV141 vector (CMV-MCS-3FLAG-SV40-Neomycin). Full-length or truncated cDNAs of RIPK1 and RIPK3 were cloned into KpnI and XhoI sites of the GV219 vector (CMV-MCS-SV40-Neomycin) with an N-terminal Myc tag. The mutRHIM of RIPK1 and RIPK3 were generated by overlap extension PCR to change RIPK1 aa539–542 from IQIG to AAAA and RIPK3 aa458–461 from VQVG to AAAA. Plasmid transfections were performed using Lipofectamine 2000 from Invitrogen according to the manufacturer’s protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!